Types of Brain Tumors: How Each One Works and When It Is Used

The word arrives before anything else does. Someone leaves a radiology suite with a scan report that says “mass,” and by the time they reach the parking lot they have searched it twice. What they find is a thicket of Greek-rooted names, each one sounding equally alarming, none of them explaining what the thing actually does inside a skull.

That gap is worth closing. A brain tumor is not one disease. It is a family of dozens, and the members behave nothing alike. One may sit quietly on the surface of the brain for twenty years. Another can double in size within weeks. The name on the report tells you which of those stories is more likely, which is why the name matters so much more than the size.

This guide walks through the main types, how each one grows and causes trouble, and when doctors use each label. Where the evidence is settled, we say so. Where it is not, we say that too.

What do doctors mean by a "type" of brain tumor?

Every brain tumor gets sorted by two questions before anything else. Where did it start? And what kind of cell went wrong?

The first question splits the field in half. A primary brain tumor begins in the brain or its coverings. A metastatic (secondary) tumor began somewhere else, most often the lung, breast, kidney, colon, or skin, and traveled to the brain through the bloodstream. According to Mayo Clinic, secondary tumors are considerably more common than primary ones, a fact that surprises most people, who assume “brain tumor” means the brain was the source.

The second question names the tissue of origin. The brain is built from neurons, but neurons almost never form tumors in adults. The troublemakers are the support cells: glial cells that feed and insulate neurons, the meninges that wrap the brain like cling film, the pituitary gland dangling beneath it, and the sheaths that coat nerves as they exit the skull. Each of these gives its name to a tumor family, which is why the labels sound so foreign. Glioma means glial. Meningioma means meninges. The suffix simply means growth.

Layered on top of both questions is grade, which we cover next. Put together, a report such as “grade 2 astrocytoma” tells a clinician three things at once: it started in the brain, it came from star-shaped glial cells, and it is slow-growing but not entirely tame. That sentence, dense as it is, is the beginning of a plan.

How are brain tumors graded, and why does grade matter more than size?

A walnut-sized tumor can be far less dangerous than one the size of a grape. What separates them is grade.

The World Health Organization classification, which the NHS and Mayo Clinic both use as their reference, assigns a grade from 1 to 4 based on how the cells look under a microscope and, increasingly, on their genetic signature. Grade 1 cells resemble normal tissue and divide slowly. Grade 4 cells are chaotic, divide rapidly, create their own blood supply, and often show areas of dead tissue where growth has outpaced nutrition.

Doctors also use the words benign and malignant, but in the brain those words carry an asterisk. A benign tumor elsewhere in the body may be a nuisance. A benign tumor pressing on the brainstem, where breathing and heart rate are regulated, can be life-threatening despite never spreading a single cell. The skull is a closed box. Anything that takes up room inside it displaces something that was already there.

Grade also predicts behavior over time. Lower-grade gliomas, for example, can slowly transform into higher grades over years, which is one reason clinicians monitor them with repeat imaging rather than treating a single scan as the final word. Metastatic tumors are not graded on this scale at all; their behavior is set by the original cancer.

One more distinction worth knowing: grade is not the same as stage. Staging describes how far a cancer has spread through the body. Primary brain tumors very rarely leave the central nervous system, so they are graded but almost never staged.

Gliomas: how astrocytomas, oligodendrogliomas, and ependymomas behave

Glial cells outnumber neurons and do the unglamorous work of the brain: feeding, insulating, clearing waste. When they turn cancerous, the result is a glioma, and gliomas as a group are the most common malignant primary brain tumors in adults, per the National Cancer Institute.

Three subtypes account for most cases, named after the cell that went astray.

Astrocytomas arise from astrocytes, the star-shaped cells that regulate blood flow and nutrients. They span the full grade range. A grade 1 pilocytic astrocytoma in a child can often be removed entirely and never return. A grade 4 astrocytoma is glioblastoma, covered in its own section below.

Oligodendrogliomas come from the cells that manufacture myelin, the fatty insulation around nerve fibers. They tend to grow slowly, often present first with a seizure, and carry a distinctive genetic fingerprint that laboratories now test for routinely. That fingerprint matters because it is associated with a more indolent course and a different response to therapy.

Ependymomas start in the cells lining the fluid-filled ventricles and the central canal of the spinal cord. Because of that location, they can block the flow of cerebrospinal fluid and raise pressure inside the head. They are more common in children than adults.

What unites gliomas is a habit of infiltrating. Rather than forming a neat ball with a capsule, glial tumor cells thread outward along white-matter tracts, mingling with healthy tissue. Surgeons describe removing “as much as is safely possible” precisely because the edge is rarely a clean line. This infiltration, not size, is what makes gliomas harder to cure than most other primary brain tumors.

What is the deadliest type of brain tumor? Understanding glioblastoma

Ask the question plainly and the answer is glioblastoma, a grade 4 astrocytoma. Johns Hopkins Medicine describes it as the most common malignant primary brain tumor in adults, and it is the one most people are thinking of when they say brain cancer.

Three features explain its reputation. It grows fast, sometimes visibly changing between scans a few weeks apart. It infiltrates aggressively, sending microscopic tendrils well beyond what imaging shows, so even a complete-looking removal leaves cells behind. And it is genetically diverse within a single tumor, which means a treatment that kills one population of cells may leave a resistant population to regrow.

Cleveland Clinic reports an average survival of roughly 12 to 18 months after diagnosis with standard treatment, with a minority of patients living considerably longer. That figure deserves context. It is a median, not a sentence; it has improved over the past two decades as surgery, radiation planning, and chemotherapy scheduling have been refined; and it varies with age, general health, the tumor’s molecular profile, and how much can be safely removed.

Glioblastoma typically appears in adults over 50, though it can occur at any age. Symptoms often arrive over weeks rather than years: headaches that worsen, new seizures, personality changes noticed first by family, or weakness on one side.

Honesty matters here. Glioblastoma is not currently curable, and no responsible clinician promises otherwise. What treatment does offer is time, symptom control, and, for many patients, months or years of meaningful function. Research into targeted and immune-based approaches is active, and clinical trials are a legitimate part of care rather than a last resort.

Meningiomas: the most common brain tumor most people have never heard of

If you picked a random adult with a primary brain tumor, the single most likely diagnosis would not be a cancer at all. It would be a meningioma, which Johns Hopkins Medicine identifies as the most common primary brain tumor, accounting for roughly one in three.

Meningiomas grow from the meninges, the three-layered membrane between skull and brain. Crucially, they grow on the brain rather than into it. Picture a marble pressing into a sponge: the sponge is dented, but the marble stays separate. That separation is why the large majority are grade 1 and why surgery, when needed, can often remove them completely.

They are also slow. Many meningiomas are discovered by accident on a scan ordered for an unrelated reason, sitting quietly with no symptoms at all. Mayo Clinic notes that small, symptom-free meningiomas are frequently watched with periodic imaging rather than treated. For some people the tumor never grows enough to matter.

When symptoms do occur, they depend entirely on location. A meningioma near the optic nerve dims vision. One over the motor strip causes weakness or seizures. One at the base of the skull can affect smell, hearing, or balance. The tumor itself does not hurt; the pressure it exerts does.

Meningiomas are more common in women than men and more common with age. A small fraction, grade 2 and 3, grow faster and can recur after removal, which is why pathology on the removed tissue guides how closely someone is followed afterward.

The practical lesson: hearing “brain tumor” is frightening, but hearing “meningioma” often means a far gentler road than the word first suggests.

Pituitary tumors: how a pea-sized gland causes outsized symptoms

The pituitary hangs from the underside of the brain like a cherry on a stalk, tucked into a bony pocket behind the bridge of the nose. It weighs about as much as a paperclip. It also runs the body’s hormone economy, instructing the thyroid, adrenal glands, ovaries and testes, and regulating growth and milk production.

Tumors here are almost always noncancerous, according to Mayo Clinic, and technically they are not brain tumors at all since the gland sits outside brain tissue. They are grouped with brain tumors because of where they live and who treats them.

They cause trouble in two distinct ways.

Functioning pituitary tumors overproduce a hormone. Too much growth hormone in an adult enlarges hands, feet, and facial features over years. Too much of the hormone that drives cortisol produces weight gain around the trunk, thin skin, and high blood pressure. Too much prolactin stops periods or causes breast discharge. These patterns are often the first clue, years before anyone thinks to image the head.

Non-functioning tumors make nothing useful but grow large enough to press on neighbors. The optic nerves cross directly above the pituitary, so a classic sign is loss of peripheral vision on both sides, sometimes noticed only when someone keeps bumping into doorframes.

Because the pituitary is reachable through the nose, many of these tumors are removed without opening the skull. Others are managed with medication that shrinks the tumor or blocks the excess hormone; the choice depends on tumor type, size, and hormone profile, and is a decision for an endocrinologist working alongside a neurosurgeon.

Acoustic neuromas and other nerve sheath tumors

Twelve pairs of cranial nerves exit the brain to run the face, eyes, tongue, and ears. Each is wrapped in a protective sheath of cells, and those cells occasionally multiply into a tumor called a schwannoma. When it happens on the nerve for hearing and balance, the result is an acoustic neuroma, also called a vestibular schwannoma.

These are benign, slow, and almost never spread. Their harm comes from real estate. The nerve they grow on runs through a narrow bony canal alongside the facial nerve, and as the tumor swells it squeezes both.

The first symptom, per the NHS, is usually hearing loss in one ear, often gradual enough that people blame a phone or a noisy workplace. Ringing (tinnitus) on the same side follows. Balance problems come next, though the brain compensates so well for a slowly failing balance nerve that unsteadiness may be subtle. Large tumors can eventually cause facial numbness or weakness and, rarely, pressure on the brainstem.

Management follows the tumor’s pace. Small tumors with mild symptoms are often observed with yearly scans. Growing tumors may be treated with focused radiation or surgery, each with trade-offs around preserving hearing and facial movement that a specialist will walk through in detail.

One important flag: a person who develops acoustic neuromas on both sides, especially young, is evaluated for a genetic condition that predisposes to multiple nerve sheath tumors. Most acoustic neuromas, though, occur alone, in adults between 30 and 60, for no identifiable reason.

Medulloblastoma and other childhood brain tumors: what is different in kids

Children’s brain tumors are not miniature versions of adult ones. They arise in different locations, from different cells, and they behave differently.

In adults, most tumors sit in the cerebrum, the large upper brain. In children, a large share arise in the cerebellum and brainstem, the lower structures controlling coordination and vital functions. The NIH’s National Cancer Institute lists medulloblastoma as the most common malignant brain tumor of childhood. It begins in the cerebellum, grows fast, and has a tendency to shed cells into the cerebrospinal fluid, seeding the spine, which is why staging for this tumor includes imaging of the entire spinal cord.

Symptoms in children reflect the location: morning headaches with vomiting, clumsiness, a head tilt, or in infants a rapidly enlarging head, because their skull bones have not yet fused and can expand under pressure.

The other side of the ledger is more hopeful. Low-grade gliomas, particularly pilocytic astrocytomas, are common in children and are among the most treatable brain tumors of any age; complete removal often ends the story. Medulloblastoma itself, though aggressive, responds to combined treatment far better than most adult malignant tumors, and molecular subtyping now separates children who need intensive therapy from those who can safely receive less.

That last point reflects the biggest shift in pediatric neuro-oncology: treating the tumor’s genetics, not just its appearance, to protect a developing brain from more radiation than it needs. Long-term follow-up for hormone, hearing, and learning effects is a standard part of care.

Metastatic brain tumors: when cancer elsewhere travels to the brain

Here is the number that reorders the whole picture: more brain tumors start outside the brain than inside it. Mayo Clinic and Johns Hopkins both note that metastatic tumors are more common than all primary brain tumors combined.

The mechanism is a journey. Cancer cells break free from a tumor in the lung, breast, skin (melanoma), kidney, or colon, enter the bloodstream, and lodge in the brain’s small vessels. The brain receives about a fifth of the heart’s output at rest, so it is a frequent destination. Once there, cells establish colonies, often several at once, usually at the boundary between gray and white matter where vessels narrow.

Metastases behave differently from gliomas in one useful way: they tend to grow as discrete balls with a clearer edge, which makes them easier to target with surgery or focused radiation. They are graded not by the WHO brain scale but by the behavior of the original cancer.

Sometimes a brain metastasis is the first sign that any cancer exists. A person with no known diagnosis develops a seizure or weakness, imaging shows a lesion, and the search for the source begins. More often, metastasis appears in someone already living with cancer, either during routine surveillance or after new symptoms.

Treatment is therefore two conversations at once: managing the brain lesions and managing the underlying disease. Advances in targeted and immune-based therapies for certain cancers have meaningfully changed how long people live with brain metastases, though outcomes still vary widely by cancer type and overall health. These decisions belong to the oncology team, informed by the specific cancer involved.

What are the four most common types of brain tumors?

Different sources slice the pie differently, but the shortlist is consistent. Counting primary tumors in adults, the four most common are meningiomas, gliomas (with glioblastoma as the largest malignant subgroup), pituitary tumors, and nerve sheath tumors such as acoustic neuromas. Add metastatic tumors and you have covered the large majority of everything a neurosurgeon sees.

The table below puts them side by side. Notice how much the columns diverge: two of the four are almost always benign, one is almost always malignant, and the age patterns barely overlap.

Type	Cell of origin	Usual grade	Typical age	Common first clue
Meningioma	Meninges (brain coverings)	Grade 1 in most cases	Middle age and older; more women	Often none; found incidentally, or focal weakness/seizure
Glioma (incl. glioblastoma)	Glial support cells	Grade 2 to 4 in adults	Adults, peak over 50 for glioblastoma	Headache pattern change, seizure, personality shift
Pituitary tumor	Hormone-producing gland cells	Almost always noncancerous	Any adult age	Hormone symptoms or loss of side vision
Acoustic neuroma	Nerve sheath (Schwann) cells	Benign	Adults 30 to 60	One-sided hearing loss, tinnitus
Metastasis	Cancer from lung, breast, skin, kidney, colon	Set by original cancer	Adults with known or unknown cancer	Seizure, weakness, or found on cancer surveillance

The practical upshot is that the phrase “brain tumor” on its own carries almost no prognostic information. A pathology report does. Anyone handed a diagnosis should ask for the exact type and grade, in writing, because those two words shape every conversation that follows.

What are the 7 warning signs of brain cancer, and how reliable are they?

Search engines love a numbered list, and the “seven signs” circulating online are broadly accurate. The catch is that none of them is specific. Each is far more often caused by something ordinary. What raises concern is pattern, persistence, and combination.

Drawing on Mayo Clinic and the NHS, the signs that matter most are:

• Headaches with a new pattern: worse in the morning, worse when lying down or straining, steadily increasing over weeks, or unlike any headache you have had before.
• A seizure in an adult with no history of them, including brief episodes of staring, twitching, or lost time.
• Weakness or numbness on one side of the body, or a new clumsiness in one hand.
• Vision changes: blurring, double vision, or loss of peripheral vision.
• Speech or comprehension difficulty: trouble finding words or following conversation.
• Personality, mood, or thinking changes noticed by others, such as new apathy, irritability, or confusion.
• Nausea and vomiting without a stomach cause, especially in the morning alongside headache.

The mechanism behind most of these is pressure and location. A growing mass raises pressure inside the closed skull, producing the headache-and-vomiting pattern. Where the mass sits determines the rest: motor cortex gives weakness, occipital lobe gives vision loss, temporal lobe gives seizures and memory trouble.

Worth repeating: headache alone, without other features, is very rarely a brain tumor. Most brain tumors that cause headache also cause something else by the time they are found.

When should you see a doctor about possible brain tumor symptoms?

Most of the symptoms above have benign explanations, and a good clinician will usually find one. The point of seeing someone is not to confirm fear but to sort the ordinary from the rare quickly, with a neurological exam and, if warranted, imaging.

Make an appointment promptly if you notice a headache pattern that is genuinely new for you and building over days to weeks, one-sided hearing loss or ringing that does not resolve, gradual loss of side vision, a change in personality or thinking that family members comment on, or hormone-type changes such as unexplained enlargement of hands and feet, new milk production, or periods stopping without pregnancy.

Seek emergency care immediately for any of these red flags: a first-ever seizure; sudden weakness, numbness, or drooping on one side of the face or body; sudden loss of vision or speech; a headache described as the worst of your life or one that arrives like a thunderclap; confusion or drowsiness that is hard to rouse; or repeated vomiting with a severe headache. These can signal a tumor causing dangerous pressure, but they are also the signs of stroke and bleeding, and minutes matter regardless of cause.

Bring specifics. Note when symptoms started, what makes them better or worse, and whether anyone else has noticed changes in you. A clear timeline helps a clinician decide whether imaging is needed and how urgently.

If you already have a cancer diagnosis, tell your oncology team about any new neurological symptom without waiting for the next scheduled visit. Brain metastases are treatable most effectively when found early.

How do doctors find out which type of brain tumor it is?

Diagnosis unfolds in layers, each narrowing the possibilities.

It begins with a neurological exam: strength, reflexes, coordination, vision fields, and a conversation that tests memory and language. This localizes the problem before any machine is involved.

Imaging comes next. MRI is the workhorse for brain tumors because it distinguishes soft tissues far better than CT. A contrast agent injected into a vein highlights areas where the blood-brain barrier has broken down, which tends to happen in higher-grade tumors and metastases. Location, shape, edge, and enhancement pattern let radiologists make an educated guess about type, and for meningiomas and acoustic neuromas that guess is often confident enough to guide management without a biopsy.

For gliomas and uncertain lesions, tissue is required. A neurosurgeon obtains it either through a needle biopsy guided by imaging or during surgery to remove the tumor. A pathologist then examines the cells for grade and origin.

Here the field has changed most. The current WHO classification, as summarized by the National Cancer Institute, integrates molecular testing into the diagnosis itself. Certain gene mutations and chromosomal changes now define tumor types, not just describe them. Two tumors that look identical under a microscope can receive different names and different prognoses based on these markers, and that molecular fingerprint increasingly steers treatment choices.

Additional tests depend on the type suspected: blood hormone levels for pituitary tumors, hearing tests for acoustic neuromas, spinal imaging and fluid sampling for tumors that can seed the spine, and a body-wide search for a primary cancer when metastasis is suspected. The full report typically takes one to two weeks after tissue is obtained, though preliminary results often come sooner.

Which brain tumors are curable, and which are not?

The honest answer is a spectrum, and where a tumor lands depends on grade, location, and how completely it can be removed.

At the curable end sit most grade 1 tumors. A meningioma removed in full, a pilocytic astrocytoma in a child, a small acoustic neuroma treated before it presses on the brainstem, a pituitary tumor cleared through the nose: for many of these, treatment ends the matter, with periodic scans as insurance. “Cure” here means the tumor does not return, and for these types that outcome is common, though never guaranteed.

In the middle are low-grade gliomas and higher-grade meningiomas. These can often be controlled for many years but carry a real risk of recurrence or transformation to a higher grade. People live with them, monitored, sometimes treated in cycles.

At the far end is glioblastoma, along with some diffuse midline gliomas in children. These are not considered curable with current treatment, a statement supported by every major clinical reference including Johns Hopkins and the National Cancer Institute. The reason is biological rather than a failure of effort: the cells have infiltrated too widely and adapt too quickly. Treatment aims to extend life and preserve function, and it often achieves both for meaningful periods.

Where does that leave someone newly diagnosed? With a question worth asking directly: for this exact type and grade, what does the evidence say about outcomes, and what is the goal of treatment, cure, control, or comfort? Clinicians answer that question with less certainty than patients wish, because individual biology varies. Asking it anyway sets the terms of an honest partnership.

What matters most, in our view, is not the label alone but how quickly the right label is reached, because every other decision flows from it.

Frequently asked questions

What is the deadliest type of brain tumor?

Glioblastoma, a grade 4 astrocytoma, is the deadliest common brain tumor and the most frequent malignant primary brain tumor in adults. It grows quickly, infiltrates surrounding tissue beyond what scans show, and contains genetically varied cells that resist a single treatment. Cleveland Clinic reports average survival of roughly 12 to 18 months with standard care, though some people live considerably longer depending on age, health, molecular profile, and how much tumor can be safely removed.

What are the four most common types of brain tumors?

Among primary brain tumors in adults, the four most common are meningiomas, gliomas (including glioblastoma), pituitary tumors, and nerve sheath tumors such as acoustic neuromas. Meningiomas lead the list at roughly one in three primary tumors, per Johns Hopkins Medicine. If metastatic tumors from cancers elsewhere in the body are counted, they are more common than any primary type, which is why clinicians always ask about cancer history.

What are the 7 warning signs of brain cancer?

The seven signs most often cited are a new or changing headache pattern, a first seizure in adulthood, one-sided weakness or numbness, vision changes, speech or comprehension trouble, personality or thinking changes, and unexplained nausea or vomiting. None is specific on its own; each is far more often caused by something ordinary. Concern rises when symptoms persist, progress over weeks, or appear in combination, especially morning headache with vomiting.

Which brain tumor is not curable?

Glioblastoma is not considered curable with current treatment, and the same is true of some diffuse midline gliomas in children. Their cells spread microscopically through brain tissue so completely that surgery cannot remove them all, and they adapt rapidly to therapy. Treatment focuses on extending life and preserving function. Many other brain tumors, particularly grade 1 meningiomas, pituitary tumors, and acoustic neuromas, are frequently treated definitively with no recurrence.

Is a benign brain tumor dangerous?

It can be. Benign means the tumor does not spread or invade, but inside the closed skull any growing mass displaces brain tissue and raises pressure. A benign tumor pressing on the brainstem, optic nerves, or a major blood vessel can cause serious harm. Many benign tumors, especially small meningiomas, are simply monitored with periodic scans. Location and growth rate, not the benign label alone, determine whether treatment is needed.

What is the difference between a primary and a secondary brain tumor?

A primary brain tumor starts in the brain or its coverings, from cells such as glia, meninges, or the pituitary gland. A secondary or metastatic tumor starts as cancer elsewhere, most often lung, breast, skin, kidney, or colon, and travels to the brain through the bloodstream. Secondary tumors are more common. They also behave differently, typically forming discrete lesions with clearer edges, and their outlook depends on the original cancer rather than a brain tumor grade.

Can a brain tumor be diagnosed without a biopsy?

Sometimes. MRI with contrast shows location, shape, edge, and enhancement patterns that let radiologists identify meningiomas and acoustic neuromas with reasonable confidence, and pituitary tumors are often confirmed with hormone blood tests. For gliomas and uncertain lesions, tissue is usually required, because grade and molecular markers that define the tumor type can only be determined by examining cells directly. The decision depends on what imaging suggests and whether it would change management.

How fast do brain tumors grow?

Growth rate varies enormously by type and grade. Grade 1 meningiomas and acoustic neuromas may grow a few millimeters a year or not at all, which is why many are monitored rather than treated. Low-grade gliomas grow slowly over years but can transform to higher grades. Glioblastoma can change visibly between scans weeks apart. Metastatic tumors follow the pace of the original cancer. Grade and tumor type are the best predictors.

Are brain tumors hereditary?

Most are not. The large majority of brain tumors occur in people with no family history and no identifiable cause. A small fraction are linked to inherited genetic conditions that predispose to multiple tumors, which clinicians consider when tumors appear at a young age, on both sides, or alongside tumors elsewhere in the body. Prior radiation to the head is the best-established environmental risk factor, according to Mayo Clinic and the NHS.

What does a brain tumor headache feel like?

There is no single signature, but patterns that raise concern include headaches that are worse in the morning or when lying down, worsen with coughing or straining, steadily intensify over weeks, differ from any headache you have had before, or come with vomiting, vision changes, or weakness. Headache alone is very rarely a brain tumor. Most tumors that cause headache also cause other neurological symptoms by the time they are found.

References

• NHS — Brain tumours
• Cleveland Clinic — Glioblastoma
• MedlinePlus — Brain Tumors

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.